Clinical Trial Update: Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of Bepotastine Besilate Ophthalmic Solution for seasonal allergic conjunctivitis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Seasonal Allergic Conjunctivitis

Drugs mentioned

• Bepotastine Besilate Ophthalmic Solution (bepotastine besilate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2020-09-14